Nureca promoter holding rises to 68.09% post buyback
Nureca Limited's promoter group increased its stake to 68.09% after a buyback that concluded on December 24, 2025, with shares extinguished on January 07, 2026. The total equity share capital reduced from 100,001,750 to 95,419,200, while the number of shares held by promoters remained constant at 64,97,176.

*this image is generated using AI for illustrative purposes only.
Nureca Limited disclosed that its promoter group's shareholding increased to 68.09% following a recent buyback of equity shares. The buyback, which opened on December 18, 2025, and closed on December 24, 2025, led to the extinguishment of shares on January 07, 2026. Consequently, the promoters' equity share capital and voting rights increased, although the number of shares held by them remained unchanged at 64,97,176.
The disclosures were submitted to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 29(1) and 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquirers included Saurabh Goyal, Aryan Goyal, Payal Goyal, Smita Goyal, and Nectar Biopharma Private Limited.
The equity share capital of the company before the acquisition was 100,001,750, which reduced to 95,419,200 after the extinguishment of shares. The total diluted share capital post-acquisition stood at 95,419,200. The public shareholding decreased by 4,58,255 shares, bringing the public holding down to 31.91%.
Shareholding Pattern
The following table details the shareholding of the promoter and promoter group before and after the buyback:
| Name of Acquirer | Before the Buyback | After the Buyback | Difference | ||
|---|---|---|---|---|---|
| No. of shares | % | No. of shares | % | % | |
| Saurabh Goyal | 32,17,214 | 32.17 | 32,17,214 | 33.72 | 1.55 |
| Aryan Goyal | 11,59,185 | 11.59 | 11,59,185 | 12.15 | 0.56 |
| Payal Goyal | 20,59,928 | 20.60 | 20,59,928 | 21.59 | 0.99 |
| Smita Goyal | 7 | 0.00 | 7 | 0.00 | 0.00 |
| Nectar Biopharma Private Limited | 60,842 | 0.61 | 60,842 | 0.64 | 0.03 |
| Promoters Total | 64,97,176 | 64.97 | 64,97,176 | 68.09 | 3.12 |
| Public | 35,02,999 | 35.03 | 30,44,744 | 31.91 | -3.12 |
| Total | 1,00,00,175 | 100.00 | 95,41,920 | 100.00 |
Historical Stock Returns for Nureca
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +12.01% | +20.10% | +18.51% | -3.16% | -4.04% | -82.96% |
How will the reduced public float impact the liquidity and trading volume of Nureca Limited shares?
Does the increased promoter stake signal a potential delisting or a move to tighten corporate control?
What is the company's planned utilization of capital following the significant reduction in equity share capital?































